Latest / JACC Specialty Journals
JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials
Commentary by Corralea Kappel
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.